Table 3.
Multivariate analysis of the impact of different immune markers on overall survival in the entire patient cohort (n = 32); * outliner excluded > CD20: n = 29, CD138: n = 31, IgM: n = 31, Pax5: n = 29; bold values are significant (p < 0.05).
| Univariate | Multivariate | |||
|---|---|---|---|---|
| HR | 95% CI | p-Value | ||
| CD20 * (Low vs. high) | 0.462 | - | - | 0.376 |
| CD20-aggregates in the tumor compartment (Low vs. high) | 0.473 | - | - | 0.337 |
| CD20-aggregates in the tumor infiltration zone (Low vs. high) | 0.016 | 9.2 | 1.6–51.4 | 0.012 |
| CD138 * (Low vs. high) | 0.724 | - | - | 0.337 |
| IgM * (Low vs. high) | 0.289 | - | - | 0.459 |
| Pax5 * (Low vs. high) | 0.462 | - | - | 0.648 |
| Mib (Low vs. high) | 0.724 | - | - | 0.189 |